3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Rectal Neoplasms
6
Colonic Neoplasms
6
Stomach Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Neutropenia
2
Neoplasms
2
Colorectal Cancer Metastatic
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Advanced Solid Tumors
2
mCRC
1
Spinocerebellar Degenerations
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
High-grade Extra Pulmonary Neuroendocrine Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric and Gastroesophageal Junction Adenocarcinoma
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
apatinib
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrectomy
2
trastuzumab deruxtecan
1
taxane
1
sintilimab
1
pembrolizumab
1
durvalumab
1
disitamab vedotin
1
cabozantinib
1
Taxes
1
Tadalafil
1
SHR-1701
1
S 1 (combination)
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Indocyanine Green
1
Immunotherapy, Adoptive
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastric Adenocarcinoma
×
trifluridine tipiracil drug combination
×
1 year
×
Clear all
No trials found.